• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVAMED (ANTALYA) MULTIFILTRATEPRO SECUCAS CI-CA HD; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVAMED (ANTALYA) MULTIFILTRATEPRO SECUCAS CI-CA HD; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 36-8116-0
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 10/26/2023
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
It was reported that at the time of the event, the patient had been sedated and in the hospital for nine days following septic shock post transplant.The patient had been on dialysis for three days when the circuit was changed on the morning of (b)(6) 2023.On the night of (b)(6) 2023, to (b)(6) 2023 during the patient¿s continuous venovenous hemodialysis (cvvhd) treatment a significant and intense increase in venous pressure occurred and the generator triggered an alarm.An unidentified body was observed at the end of the venous tube, blocking the flow.It was impossible to return the patient¿s blood which resulted in approximately 300 ml of blood loss.After the reported event, dialysis was stopped for the patient, but this was unrelated the event.The sample was reported to not be available for evaluation.Additional information requested but has not been obtained.
 
Event Description
It was reported that at the time of the event, the patient had been sedated and in the hospital for nine days following septic shock post transplant.The patient had been on dialysis for three days when the circuit was changed on the morning of (b)(6) 2023.On the night of (b)(6) 2023, to (b)(6) 2023 during the patient¿s continuous venovenous hemodialysis (cvvhd) treatment a significant and intense increase in venous pressure occurred and the generator triggered an alarm.An unidentified body was observed at the end of the venous tube, blocking the flow.It was impossible to return the patient¿s blood which resulted in approximately 300 ml of blood loss.After the reported event, dialysis was stopped for the patient, but this was unrelated the event.The sample was reported to not be available for evaluation.Additional information requested but has not been obtained.
 
Manufacturer Narrative
Investigation: the complaint sample was not available for evaluation.Product batch production record controls resulted with conformity.Nonconformity was not observed during manufacturing process.There is no other complaint reported during complaint history review.The reported event is adequately documented in the instructions for use and/or the label.There is no indication that the reported failure relates to falsification.The retained samples were checked for defect, assembly failure, and leakage test which resulted in conformity.The reported event was not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MULTIFILTRATEPRO SECUCAS CI-CA HD
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
NOVAMED (ANTALYA)
antalya freezone ctr branch
liman s b mah.4. sk.no:16
konyaalti-antalya 07070
TU  07070
Manufacturer (Section G)
NOVAMED (ANTALYA)
antalya freezone ctr branch
liman s b mah.4. sk.no:16
konyaalti-antalya 07070
TU   07070
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key18237713
MDR Text Key329374089
Report Number0001225714-2023-00096
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EUA200149
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 01/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number36-8116-0
Device Lot NumberE9UC035
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 11/13/2023
Initial Date FDA Received11/30/2023
Supplement Dates Manufacturer Received12/18/2023
Supplement Dates FDA Received01/02/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ULTRAFLUX EMIC2; ULTRAFLUX EMIC2
Patient Age57 YR
Patient SexFemale
-
-